Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

With Market Size Valued at $14.3 Billion by 2026, it`s a Healthy Outlook for the Global Neuroprosthetics Market


SAN FRANCISCO, Oct. 21, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Neuroprosthetics - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

FACTS AT A GLANCE
Edition: 7; Released: April 2021
Executive Pool: 10684
Companies: 44 - Players covered include Abbott Laboratories; Boston Scientific Corporation; Cochlear Ltd.; LivaNova PLC; Medtronic PLC; NDI Medical; NeuroPace, Inc.; Nevro Corp.; Retina Implant AG; Second Sight Medical Products, Inc.; Sonova Holding AG and Others.
Coverage: All major geographies and key segments
Segments: Type (Cochlear Implants, Bionic Eye/Retinal Implants, Motor Prosthetics, Cognitive Prosthetics)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlasstm Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global Neuroprosthetics Market to Reach $14.3 Billion by 2026
Amid the COVID-19 crisis, the global market for Neuroprosthetics estimated at US$7.3 Billion in the year 2020, is projected to reach a revised size of US$14.3 Billion by 2026, growing at a CAGR of 11.7% over the analysis period. Cochlear Implants, one of the segments analyzed in the report, is projected to record a 11.6% CAGR and reach US$4.5 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bionic Eye/Retinal Implants segment is readjusted to a revised 8.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.5 Billion in 2021, While China is Forecast to Reach $2.5 Billion by 2026
The Neuroprosthetics market in the U.S. is estimated at US$2.5 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2026 trailing a CAGR of 11.2% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.5% CAGR.

Motor Prosthetics Segment to Reach US$6.4 Billion by the year 2026
In the global Motor Prosthetics segment, USA, Canada, Japan, China and Europe will drive the 12.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.4 Billion in the year 2020 will reach a projected size of US$5.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. More

MarketGlasstm Platform
Our MarketGlasstm Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyRtm
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: ZA@StrategyR.com

LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp

Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow Us on Twitter
https://twitter.com/marketbytes

Journalists & Media
Info411@strategyr.com

SOURCE Global Industry Analysts, Inc.


These press releases may also interest you

at 06:35
ImmunoGen Inc. , a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced positive top-line data from the pivotal SORAYA trial evaluating the safety and efficacy of mirvetuximab soravtansine...

at 06:35
R.R. Donnelley & Sons Company ("RRD" or the "Company") today announced that it has received a proposal from Chatham Asset Management, LLC ("Chatham") to acquire all of the outstanding shares of RRD not already owned by Chatham for $10.25 per share...

at 06:35
AstraZeneca and Merck , known as MSD outside the United States and Canada, today announced that a supplemental New Drug Application (sNDA) for LYNPARZA has been accepted and granted priority review by the U.S. Food and Drug Administration (FDA) for...

at 06:35
Apogee Enterprises, Inc. today will host its 2021 Investor Day, which will include presentations by Chief Executive Officer Ty Silberhorn, and other members of the executive leadership team. During the presentations, Apogee's leadership team will...

at 06:35
NICE today announced that it has been recognized as a Technology Leader by Quadrant Knowledge Solutions. The global advisory and consulting firm's SPARK Matrixtm: Customer Journey Analytics (CJA), 2021 report highlights that NICE's customer...

at 06:35
The fourteenth edition of the World Branding Awards saw over 500 brands from more than 60 countries named as the "Brand of the Year" and welcomed over 100 guests from around the world to connect remotely and celebrate their achievements at the Forums...



News published on 21 october 2021 at 11:55 and distributed by: